NCT07314632 Prospective Study in Laser Treatment of Pilonidal Cysts
| NCT ID | NCT07314632 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre Hospitalier Departemental Vendee |
| Condition | Pilonidal Sinus |
| Study Type | OBSERVATIONAL |
| Enrollment | 240 participants |
| Start Date | 2026-03-19 |
| Primary Completion | 2030-06-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 240 participants in total. It began in 2026-03-19 with a primary completion date of 2030-06-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to evaluate the recurrence rate after laser treatment of pilonidal sinus within two years of the procedure in adult patients who require this procedure to treat their pilonidal sinus. The main question it aims to answer is: • Is there a clinical recurrence (presence of a fistula in the intergluteal cleft) 2 years after laser treatment of pilonidal sinus? Participants who undergo surgery as part of their regular medical care will answer survey questions about recurrence at 1 and 2 years.
Eligibility Criteria
Inclusion Criteria: * Patients requiring laser surgery for pilonidal sinus, of any type (including recurrence after radical cure or laser treatment) * Patient able to understand the protocol and having given written informed consent to participate in the study, * Patient affiliated to the social security system or entitled to it. Exclusion Criteria: * Patient participating in another interventional clinical research protocol involving a drug or clinical investigation of a medical device * Patient already included in a research study * Patient under guardianship, conservatorship, or deprived of liberty * Patient under an activated future protection mandate * Patient under family authorization * Patient under judicial protection.
Contact & Investigator
Tristan GREILSAMER, PH
PRINCIPAL INVESTIGATOR
Centre Hospitalier Departemental Vendée
Frequently Asked Questions
Who can join the NCT07314632 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Pilonidal Sinus. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07314632 currently recruiting?
Yes, NCT07314632 is actively recruiting participants. Contact the research team at agnes.dorion@ght85.fr for enrollment information.
Where is the NCT07314632 trial being conducted?
This trial is being conducted at Cornebarrieu, France, La Roche-sur-Yon, France.
Who is sponsoring the NCT07314632 clinical trial?
NCT07314632 is sponsored by Centre Hospitalier Departemental Vendee. The principal investigator is Tristan GREILSAMER, PH at Centre Hospitalier Departemental Vendée. The trial plans to enroll 240 participants.